{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T10:53:35Z","timestamp":1784976815156,"version":"3.55.0"},"reference-count":27,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2021,10,2]],"date-time":"2021-10-02T00:00:00Z","timestamp":1633132800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>The role of therapeutic drug monitoring (TDM) of valaciclovir (VA)\/aciclovir (A) and valganciclovir\/ganciclovir (VG\/G) in critically ill patients is still a matter of debate. More data on the dose\u2013concentration relationship might therefore be useful, especially in pediatrics where clinical practice is not adequately supported by robust PK studies. We developed and validated a new liquid chromatography-tandem mass spectrometry (LC-MS\/MS) micro-method to simultaneously quantify A and G from plasma and dried plasma spots (DPS). The method was based on rapid organic extraction from DPS and separation on a reversed-phase C-18 UHPLC column after addition of deuterated internal standards. Accurate analyte quantification using SRM detection was then obtained using a Thermo Fisher Quantiva triple-quadrupole MS coupled to an Ultimate 3000 UHPLC. It was validated following international (EMA) guidelines for bioanalytical method validation and was tested on samples from pediatric patients treated with A, VG, or G for cytomegalovirus infection following solid organ or hematopoietic stem cell transplantation. Concentrations obtained from plasma and DPS were compared using Passing\u2013Bablok and Bland\u2013Altman statistical tests. The assay was linear over wide concentration ranges (0.01\u201320 mg\/L) in both plasma and DPS for A and G, suitable for the expected therapeutic ranges for both Cmin and Cmax, accurate, and reproducible in the absence of matrix effects. The results obtained from plasma and DPS were comparable. Using an LC-MS\/MS method allowed us to obtain a very specific, sensitive, and rapid quantification of these antiviral drugs starting from very low volumes (50 \u03bcL) of plasma samples and DPS. The stability of analytes for at least 30 days allows for cost-effective shipment and storage at room temperature. Our method is suitable for TDM and could be helpful for improving knowledge on PK\/PD targets of antivirals in critically ill pediatric patients.<\/jats:p>","DOI":"10.3390\/biomedicines9101379","type":"journal-article","created":{"date-parts":[[2021,10,4]],"date-time":"2021-10-04T09:24:15Z","timestamp":1633339455000},"page":"1379","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["A UHPLC\u2013MS\/MS Method for Therapeutic Drug Monitoring of Aciclovir and Ganciclovir in Plasma and Dried Plasma Spots"],"prefix":"10.3390","volume":"9","author":[{"given":"Federica","family":"Pigliasco","sequence":"first","affiliation":[{"name":"Chromatography and Mass Spectrometry Section, Central Laboratory of Analysis, IRCCS Istituto Giannina Gaslini, 16147 Genoa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Cafaro","sequence":"additional","affiliation":[{"name":"Chromatography and Mass Spectrometry Section, Central Laboratory of Analysis, IRCCS Istituto Giannina Gaslini, 16147 Genoa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3989-7703","authenticated-orcid":false,"given":"Raffaele","family":"Simeoli","sequence":"additional","affiliation":[{"name":"Department of Pediatric Specialties, Division of Metabolic Biochemistry, Children\u2019s Hospital Bambino Ges\u00f9, IRCCS, 00165 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1148-427X","authenticated-orcid":false,"given":"Sebastiano","family":"Barco","sequence":"additional","affiliation":[{"name":"Chromatography and Mass Spectrometry Section, Central Laboratory of Analysis, IRCCS Istituto Giannina Gaslini, 16147 Genoa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Magnasco","sequence":"additional","affiliation":[{"name":"Pediatric Nephrology, IRCCS Istituto Giannina Gaslini, 16147 Genoa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5715-501X","authenticated-orcid":false,"given":"Maura","family":"Faraci","sequence":"additional","affiliation":[{"name":"Hematopoietic Stem Cell Unit, Department of Pediatric Hematology and Oncology, IRCCS Istituto Giannina Gaslini, 16147 Genoa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gino","family":"Tripodi","sequence":"additional","affiliation":[{"name":"Chromatography and Mass Spectrometry Section, Central Laboratory of Analysis, IRCCS Istituto Giannina Gaslini, 16147 Genoa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca Maria","family":"Goffredo","sequence":"additional","affiliation":[{"name":"Department of Pediatric Specialties, Division of Metabolic Biochemistry, Children\u2019s Hospital Bambino Ges\u00f9, IRCCS, 00165 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuliana","family":"Cangemi","sequence":"additional","affiliation":[{"name":"Chromatography and Mass Spectrometry Section, Central Laboratory of Analysis, IRCCS Istituto Giannina Gaslini, 16147 Genoa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,10,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s00134-020-06050-1","article-title":"Antimicrobial therapeutic drug monitoring in critically ill adult patients: A Position Paper#","volume":"46","author":"Alffenaar","year":"2020","journal-title":"Intensive Care Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S1473-3099(14)70036-2","article-title":"Individualised antibiotic dosing for patients who are critically ill: Challenges and potential solutions","volume":"14","author":"Roberts","year":"2014","journal-title":"Lancet Infect. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1093\/jac\/dkv165","article-title":"The ADMIN-ICU survey: A survey on antimicrobial dosing and monitoring in ICUs","volume":"70","author":"Tabah","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1093\/jac\/dkt523","article-title":"An international, multicentre survey of \u03b2-lactam antibiotic therapeutic drug monitoring practice in intensive care units","volume":"69","author":"Wong","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/1120009X.2017.1377909","article-title":"Pharmacokinetic\/pharmacodynamic parameters for treatment optimization of infection due to antibiotic resistant bacteria: A summary for practical purposes in children and adults","volume":"30","author":"Gustinetti","year":"2018","journal-title":"J. Chemother."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1086\/515385","article-title":"Valaciclovir for the suppression of recurrent genital herpes simplex virus infection: A large-scale dose range-finding study","volume":"178","author":"Reitano","year":"1998","journal-title":"J. Infect. Dis."},{"key":"ref_7","unstructured":"(2021, August 24). Corr Guideline on Bioanalytical Method Validation. Available online: https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/guideline-bioanalytical-method-validation_en.pdf."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"8959","DOI":"10.1021\/ac5018265","article-title":"Selecting the correct weighting factors for linear and quadratic calibration curves with least-squares regression algorithm in bioanalytical LC-MS\/MS assays and impacts of using incorrect weighting factors on curve stability, data quality, and assay perfo","volume":"86","author":"Gu","year":"2014","journal-title":"Anal. Chem."},{"key":"ref_9","first-page":"431","article-title":"Comparison of Several Regression Procedures for Method Comparison Studies and Determination of Sample Sizes Application of linear regression procedures for method comparison studies in Clinical Chemistry, Part II","volume":"22","author":"Passing","year":"2009","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0140-6736(86)90837-8","article-title":"Statistical Methods for Assessing Agreement Between Two Methods of Clinical Measurement","volume":"327","author":"Altman","year":"1986","journal-title":"Lancet"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.cca.2013.09.049","article-title":"Measurement of ganciclovir concentration in human plasma by ultra-performance liquid chromatography-tandem mass spectrometry","volume":"427","author":"Cerezo","year":"2014","journal-title":"Clin. Chim. Acta"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1001\/archinte.1996.00440140169018","article-title":"A large-scale, placebo-controlled, dose-ranging trial of peroral valaciclovir for episodic treatment of recurrent herpes genitalis","volume":"156","author":"Spruance","year":"1996","journal-title":"Arch. Intern. Med."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Weller, S., Blum, M.R., Doucette, M., Burnette, T., Cederberg, D.M., De Miranda, P., and Smiley, M.L. (2000). Pharmacolunetics of the acvclovir pro- drug valaciclovir after iscalati and multiple-dose adrninis tration normal volunteers. Clin. Pharmacol. Ther., 595\u2013605.","DOI":"10.1038\/clpt.1993.196"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1399-3062.2011.00685.x","article-title":"Analysis and clinical correlation of genetic variation in cytomegalovirus","volume":"14","author":"Lisboa","year":"2012","journal-title":"Transpl. Infect. Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1007\/s10096-009-0806-5","article-title":"Oral valganciclovir treatment in newborns with symptomatic congenital cytomegalovirus infection","volume":"28","author":"Lombardi","year":"2009","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ijantimicag.2010.11.033","article-title":"Ganciclovir treatment in children: Evidence of subtherapeutic levels","volume":"37","author":"Luck","year":"2011","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.jchromb.2010.12.033","article-title":"Determination of Ganciclovir and its prodrug Valganciclovir by hydrophilic interaction liquid chromatography-tandem mass spectrometry","volume":"879","author":"Heinig","year":"2011","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1365\/s10337-009-1171-3","article-title":"An LC-MS-MS method for the simultaneous quantitation of acyclovir and valacyclovir in human plasma","volume":"70","author":"Kanneti","year":"2009","journal-title":"Chromatographia"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.jchromb.2009.01.042","article-title":"Stability evaluation and sensitive determination of antiviral drug, valacyclovir and its metabolite acyclovir in human plasma by a rapid liquid chromatography-tandem mass spectrometry method","volume":"877","author":"Yadav","year":"2009","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/bmc.1192","article-title":"Simultaneous determination of acyclovir, ganciclovir, and (R)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine in human plasma using high-performance liquid chromatography","volume":"23","author":"Weller","year":"2009","journal-title":"Biomed. Chromatogr."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/(SICI)1099-0801(200004)14:2<93::AID-BMC932>3.0.CO;2-0","article-title":"A rapid and sensitive method for the quantification of ganciclovir in plasma using liquid chromatography\/selected reaction monitoring\/mass spectrometry","volume":"14","author":"Xu","year":"2000","journal-title":"Biomed. Chromatogr."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jchromb.2006.10.053","article-title":"A sensitive assay for simultaneous determination of plasma concentrations of valganciclovir and its active metabolite ganciclovir by LC\/MS\/MS","volume":"848","author":"Xu","year":"2007","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"113181","DOI":"10.1016\/j.jpba.2020.113181","article-title":"Validation of an assay for quantifying ganciclovir in dried blood spots","volume":"184","author":"Rower","year":"2020","journal-title":"J. Pharm. Biomed. Anal."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.jpba.2010.02.026","article-title":"HPLC-MS method for the quantification of nine anti-HIV drugs from dry plasma spot on glass filter and their long term stability in different conditions","volume":"52","author":"Simiele","year":"2010","journal-title":"J. Pharm. Biomed. Anal."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1093\/jac\/dks285","article-title":"Development and validation of a new method to simultaneously quantify triazoles in plasma spotted on dry sample spot devices and analysed by HPLC-MS","volume":"67","author":"Baietto","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.jpba.2016.08.002","article-title":"Development and validation of UHPLC\u2013MS\/MS methods for the quantification of colistin in plasma and dried plasma spots","volume":"129","author":"Cangemi","year":"2016","journal-title":"J. Pharm. Biomed. Anal."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/FTD.0000000000000600","article-title":"LC-MS\/MS-Based Quantification of 9 Antiepileptic Drugs From a Dried Sample Spot Device","volume":"41","author":"Cangemi","year":"2019","journal-title":"Ther. Drug Monit."}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/9\/10\/1379\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:08:54Z","timestamp":1760166534000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/9\/10\/1379"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,2]]},"references-count":27,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021,10]]}},"alternative-id":["biomedicines9101379"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines9101379","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,2]]}}}